NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
BUZZ-NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results ** Shares of AFT Pharmaceuticals Ltd AFT.NZ advance as much as 1.9% to NZ$4.38, their biggest intraday pct gain since September 23
** Stock hits highest level since September 29
** Pharmaceutical distributor reports H1FY27 results, posts double-digit revenue growth across all its divisions
** Co affirms FY27 operating profit guidance between NZ$28 million ($15.68 million) and NZ$32 million
** Sales on track to meet target of NZ$300 million for the fiscal year, AFT adds
** Stock up 29.6% YTD, including the day's moves
($1 = 1.7854 New Zealand dollars)
(Reporting by Rudrannsh Mehra in Bengaluru)
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV